For the Inventor, By the Inventor

Enter assignee name

Kvistgaard, Denmark

Bavarian Nordic A/s

Calculating rank

USPTO Granted Patents = 136

% Expired Patents = 36.0

CIPO Patents = 10

EPO Patents = 39

Trademarks = 17

Forward Citations = 933

Loading Chart...

Loading Chart...

83 inventors (with patents filed for the assignee):

Paul Michael Howley (45 out of 49 patents)

Paul Chaplin (39 out of 39 patents)

Robin Steigerwald (27 out of 27 patents)

4. Sonja Leyrer (26 out of 27 patents)

5. Eva Felder (24 out of 24 patents)

6. Hubertus Hochrein (16 out of 16 patents)

7. Christine Meisinger-Henschel (16 out of 16 patents)

8. Karl Heller (13 out of 13 patents)

9. Markus Kalla (11 out of 11 patents)

10. Jürgen Hausmann (11 out of 11 patents)

11. Ulrike Dirmeier (10 out of 10 patents)

12. Ingmar Rathe (10 out of 10 patents)

13. Ariane Volkmann (9 out of 9 patents)

14. Henning Lauterbach (8 out of 8 patents)

15. Sara Post Hansen (8 out of 8 patents)

Core Competencies:

Poxvirus

MVA

Cancer Therapy

HIV Antigens

Filovirus Immunity

Vaccine Composition

Immune Response

Transgene Stability

RSV Vaccine

Promoter Elements

Dendritic Cells

Infection Protection

136 patents: Sort by Forward Citations

1. 12758628 - Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer (2026-10-13),

2. 12746282 - A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus Disease (2026-09-29),

3. 12648992 - Conditions improving poxvirus stability (2026-06-09),

4. 12644125 - Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus Vectors (2026-06-02),

5. 12390515 - Therapy for treating cancer with an intratumoral or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40L (2025-08-19),

6. 12150988 - Storage improved poxvirus compositions (2024-11-26),

7. 11918639 - Methods and compositions for inducing protective immunity against filovirus infection (2024-03-05),

8. 11753652 - Cassette encoding a FPV/brachyury fusion protein (2023-09-12),

9. 11723970 - Poxvirus vectors encoding HIV antigens, and methods of use thereof (2023-08-15),

10. 11723964 - Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA (2023-08-15),

11. 11654189 - Compositions and methods for enhancing the stability of transgenes in poxviruses (2023-05-23),

12. 11571471 - Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine (2023-02-07),

13. 11338030 - Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens (2022-05-24),

14. 11273211 - Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody (2022-03-15),

15. 11229693 - Poxvirus vectors encoding HIV antigens, and methods of use thereof (2022-01-25),

Company Overview

Bavarian Nordic A/S, headquartered in Kvistgaard, Denmark, is a biotechnology company specializing in the development of innovative vaccines, particularly in the field of poxvirus vaccines. The company focuses on advanced technologies such as Modified Vaccinia Ankara (MVA) for applications in cancer therapy and infectious diseases, including HIV and filovirus immunity. Bavarian Nordic is dedicated to enhancing immune responses through its proprietary vaccine compositions, contributing significantly to global health initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

136 Patents

#1 in Kvistgaard

#30 in Denmark

#5,952 in the World

Kvistgaard, Denmark

Bavarian Nordic A/s

Forward Citations = 933

83 inventors:

Paul Michael Howley (45 out of 49 patents)

Paul Chaplin (39 out of 39 patents)

Robin Steigerwald (27 out of 27 patents)

4. Sonja Leyrer (26 out of 27 patents)

5. Eva Felder (24 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bavarian Nordic A/s. Retrieved from https://idiyas.com/company/bavarian-nordic-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…